Josh Denny

Six Vanderbilt physicians honored by medical societies

Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:

Nashville Biosciences created to leverage wealth of data

Officials with Vanderbilt University Medical Center announced the creation of a wholly owned subsidiary, Nashville Biosciences, to harness the power of its extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Deciphering DNA code

Study spots undiagnosed genetic diseases in EHR

Patients diagnosed with heart failure, stroke, infertility and kidney failure could actually be suffering from rare and undiagnosed genetic diseases.

Study reveals safety signal from genes that mimic drugs

Prospective mothers taking a new class of cholesterol-lowering drugs might incur higher risk of spina bifida in their future children, according to a study published in the journal Drug Safety by researchers at Vanderbilt University Medical Center.

Precision medicine discussion

Consuelo Wilkins, M.D., MSCI, and Joshua Denny, M.D., M.S., discussed the potential of precision medicine during their recent Flexner Discovery Lecture.

Vanderbilt’s Buntin, Denny elected to National Academy of Medicine

Vanderbilt University’s Melinda Buntin, Ph.D., professor of Health Policy and chair of the department, and Joshua Denny, M.D., M.S., professor of Biomedical Informatics and Medicine and Vice President for Personalized Medicine, are among 70 new members elected to the National Academy of Medicine (NAM), the organization announced this week.

1 2 3 4